Diabetes Management Market CAGR is expected to be 23.7% during the forecast period and the market size is expected to reach nearly US$ 57.83 Bn. by 2029. The report focuses on the diabetes management market value at the top regions and countries of the world, which shows a regional development, including market size, share, revenue, and much more across the globe. The report has covered, capacity, production value, cost/profit, and supply/demand by statistical analysis. A brief analysis of drivers, restraints, opportunities, and challenges in the market is also covered with examples by region.To know about the Research Methodology :- Request Free Sample Report
Diabetes Management Market Introduction and Market scenario:
Diabetes, scientifically identified as diabetes mellitus, is a clinical condition where a person has a higher blood glucose level. It happens because of either inefficiency of the pancreases to produce insulin (Type I) or unresponsiveness of body cells to the produced insulin (Type II) or both. This condition especially results in polyuria, increase in thrust and hunger. The rising occurrence of diabetes is the main factor driving the demand for diabetes management devices and anti-diabetic drugs. The growing elderly population, the global rising prevalence of diabetes, increasing acceptance of novel drugs such as incretin & dipeptidyl inhibitors, technological advancements in diabetes devices, and the existence of government initiatives are other factors attributed to the market growth over the forecast period. According to, the International Diabetes Federation, in 2021, approximately 463 million people were living with diabetes and this number is expected to reach 700 million by 2045. Such a fast-increasing rate of diabetes population has fueled the demand for insulin management and delivery devices over the past few years and is expected to increase further in the future. The increasing occurrence of obesity and the growing inclination for combination therapy across the globe is expected to support market growth. The manufacturers of insulin pens are inclined on including advanced features to the product such as an easy interface for diabetes patients. For example, in 2021, Medtronic launched the latest version of its smart insulin pen, which features integrated continuous glucose monitoring (CGM). According to the company, it is the first-ever "connected" device designed for diabetes patients using multiple daily injections of insulin. However, the high cost of devices and therapeutics is expected to control the market growth over the forecast period. Also, the global diabetes management market suffers from some of the serious restraints that are, counterfeiting of drugs, lack of healthcare personnel in some countries such as Russia, cost sensitivity, and limited infrastructure for management.COVID-19 Impact on Global Diabetes Management Market:
Diabetes management is an important healthcare area that demands regular care and attention. Now, the COVID-19 pandemic has significantly changed the digital healthcare industry. During the hard times of COVID-19, many diabetic patients have obtained digital solutions for diabetes management, which is added as a boost to the global market and has unlocked new growth opportunities.Diabetes Management Market Segment Overview:
The diabetes management market is segmented by type of devices into monitoring, diagnostic, insulin delivery, and other devices. Among these, the monitoring device type, the blood glucose meters segment is expected to dominate the market during the forecast period due to the increasing need for blood glucose level monitoring to manage diabetes efficiently. Also, the insulin delivery devices have increased its sale to favorable value, which has resulted in improvement in insulin delivery technology. In the insulin delivery devices segment, insulin pens are expected to grow at the highest CAGR of XX% during the forecast period, on accounts of it is more popular as they are less painful in usage. The global diabetes management market is segmented by therapeutics into two broad categories, namely injectables and orally administered drugs. Among these, the injectables segment is expected to hold the largest market share of XX% in the diabetes management market in the future, due to the rising inclination for insulin from patients. The dipeptidyl inhibitors segment is expected to register relatively higher market growth owing to its safe nature and once-daily dose regimen.Diabetes Management Market Regional Insights:
The diabetes management market is segmented into North America, Europe, Asia Pacific, and Latin America, and ME&A. BRICS countries are expected to hold the largest market share of XX% of the market, due to the growing geriatric population and increasing incidences of diabetes in Brazil, Russia, India, China, and South Africa. Also, North America is expected to grow at the highest CAGR of XX% in the future, attributed to the changing lifestyle of individuals and rising prevalence of diabetes & obesity in the U.S., Canada, and Mexico. The Asia Pacific is the second-largest market for the diabetes management market. This is mainly because of the high incidences of diabetes and a large pool of an aged population. The developing country in the Asia Pacific such as China is growing as one of the major pharma markets for diabetes care and management.Recent Industry Development:
On June 15, 2021, Abbott Laboratories has received FDA clearance for its new continuous glucose meter, which is Freestyle Libre2. This new device is another challenger in the growing market for CGM. The new device is used in children above 4years and adults too, and this is applied on the back of the upper arm. This new version adds an advantage for users in setting the alarm in people whose glucose levels are too high or low. On February 19, 2021, Dexcom collaborates with DreaMed to couple Dexcom continuous glucose monitors, and the DreaMed Advisor is a digital solution that generates insulin delivery by investigating information from continuous glucose monitoring self-monitoring blood glucose, and insulin delivery devices. On April 30, 2021, Roche Diagnostics has announced free access for the mySugr Pro app in assisting millions of people who have diabetes to maintain their personalized daily diabetes during the COVID-19 crisis. The objective of the report is to present a comprehensive analysis of the Global Diabetes Management Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Diabetes Management Market dynamics, structure by analyzing the market segments and project the Global Diabetes Management Market size. Clear representation of competitive analysis of key players by application, price, financial position, product portfolio, growth strategies, and regional presence in the Global Diabetes Management Market make the report investor’s guide.Diabetes Management Market, Key Highlights:
• Global Diabetes Management Market analysis and forecast, in terms of value. • Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Diabetes Management Market • Global Diabetes Management Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided. • Global Diabetes Management Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. • Global Diabetes Management Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. • Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. • Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Diabetes Management Market are also profiled.Diabetes Management Market Scope: Inquire before buying
Global Diabetes Management Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 10.55 Bn. Forecast Period 2022 to 2029 CAGR: 23.7 % Market Size in 2029: US $ 57.83 Bn. Segments Covered: by Device Type • Monitoring Devices o Blood Glucose Meters o Lancets o Blood Sampling Devices • Diagnostic Devices o Hemoglobin A1c o Hemoglobin A1c Kits o Hemoglobin A1c Meters • Insulin Delivery Devices o Insulin Pumps o Insulin Pens o Disposable Insulin Pens o Insulin Syringes o Reusable Insulin Pens • Other Devices o Artificial Pancreas o Commercial Software o Software Programs for Diabetes Monitoring o Web Software by Therapeutics • Injectables o Insulin o Exenatide • Oral Drugs o Metformin o Sulfonylureas o Alpha glycosidase Inhibitors o Dipeptidyl Inhibitors o Meglitinides o Thaizolidinediones o Combination Medications Diabetes Management Market, by Region
• North America • Europe • Asia Pacific • Middle East & Africa • South AmericaDiabetes Management Market, Key Players
• Abbott Laboratories • Bayer AG • Bristol-Myers Squibb • Eli Lilly and Co. • Sanofi • Dexcom • Medtronic • Novo Nordisk A/S • ZydusCadila • BD • Merck & Co. Inc. • F. Hoffmann-La Roche Ltd • Insulet Corporation • Life Scan, Inc. • B. Braun • Tandem Diabetes Care • Ascensia Diabetes Care • Tidepool • Others Frequently Asked Questions: 1. Which region has the largest share in Global Diabetes Management Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Diabetes Management Market? Ans: The Global Diabetes Management Market is growing at a CAGR of 23.7 %during forecasting period 2022-2029. 3. What is scope of the Global Diabetes Management market report? Ans: Global Diabetes Management Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Diabetes Management market? Ans: The important key players in the Global Diabetes Management Market are – Abbott Laboratories, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi, Dexcom, Medtronic, Novo Nordisk A/S, ZydusCadila, BD, Merck & Co. Inc., F. Hoffmann-La Roche Ltd, Insulet Corporation, LifeScan, Inc., B. Braun, Tandem Diabetes Care, Ascensia Diabetes Care, and Tidepool 5. What is the study period of this market? Ans: The Global Diabetes Management Market is studied from 2021 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Diabetes Management Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Diabetes Management Market 3.4. Geographical Snapshot of the Diabetes Management Market, By Manufacturer share 4. Global Diabetes Management Market Overview, 2021-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Diabetes Management Market 5. Supply Side and Demand Side Indicators 6. Global Diabetes Management Market Analysis and Forecast, 2021-2029 6.1. Global Diabetes Management Market Size & Y-o-Y Growth Analysis. 7. Global Diabetes Management Market Analysis and Forecasts, 2021-2029 7.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 7.1.1. Monitoring Devices 7.1.1.1. Blood Glucose Meters 7.1.1.2. Lancets 7.1.1.3. Blood Sampling Devices 7.1.2. Diagnostic Devices 7.1.2.1. Hemoglobin A1c 7.1.2.2. Hemoglobin A1c Kits 7.1.2.3. Hemoglobin A1c Meters 7.1.3. Insulin Delivery Devices 7.1.3.1. Insulin Pumps 7.1.3.2. Insulin Pens 7.1.3.3. Disposable Insulin Pens 7.1.3.4. Insulin Syringes 7.1.3.5. Reusable Insulin Pens 7.1.4. Other Devices 7.1.4.1. Artificial Pancreas 7.1.4.2. Commercial Software 7.1.4.3. Software Programs for Diabetes Monitoring 7.1.4.4. Web Software 7.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 7.2.1. Injectables 7.2.1.1. Insulin 7.2.1.2. Exenatide 7.2.2. Oral Drugs 7.2.2.1. Metformin 7.2.2.2. Sulfonylureas 7.2.2.3. Alpha glycosidase Inhibitors 7.2.2.4. Dipeptidyl Inhibitors 7.2.2.5. Meglitinides 7.2.2.6. Thaizolidinediones 7.2.2.7. Combination Medications 8. Global Diabetes Management Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2021-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Diabetes Management Market Analysis and Forecasts, 2021-2029 9.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 9.1.1. Monitoring Devices 9.1.1.1. Blood Glucose Meters 9.1.1.2. Lancets 9.1.1.3. Blood Sampling Devices 9.1.2. Diagnostic Devices 9.1.2.1. Hemoglobin A1c 9.1.2.2. Hemoglobin A1c Kits 9.1.2.3. Hemoglobin A1c Meters 9.1.3. Insulin Delivery Devices 9.1.3.1. Insulin Pumps 9.1.3.2. Insulin Pens 9.1.3.3. Disposable Insulin Pens 9.1.3.4. Insulin Syringes 9.1.3.5. Reusable Insulin Pens 9.1.4. Other Devices 9.1.4.1. Artificial Pancreas 9.1.4.2. Commercial Software 9.1.4.3. Software Programs for Diabetes Monitoring 9.1.4.4. Web Software 9.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 9.2.1. Injectables 9.2.1.1. Insulin 9.2.1.2. Exenatide 9.2.2. Oral Drugs 9.2.2.1. Metformin 9.2.2.2. Sulfonylureas 9.2.2.3. Alpha glycosidase Inhibitors 9.2.2.4. Dipeptidyl Inhibitors 9.2.2.5. Meglitinides 9.2.2.6. Thaizolidinediones 9.2.2.7. Combination Medications 10. North America Diabetes Management Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Diabetes Management Market Analysis and Forecasts, 2021-2029 11.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 11.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 12. Canada Diabetes Management Market Analysis and Forecasts, 2021-2029 12.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 12.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 13. Mexico Diabetes Management Market Analysis and Forecasts, 2021-2029 13.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 13.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 14. Europe Diabetes Management Market Analysis and Forecasts, 2021-2029 14.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 14.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 15. Europe Diabetes Management Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Diabetes Management Market Analysis and Forecasts, 2021-2029 16.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 16.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 17. France Diabetes Management Market Analysis and Forecasts, 2021-2029 17.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 17.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 18. Germany Diabetes Management Market Analysis and Forecasts, 2021-2029 18.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 18.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 19. Italy Diabetes Management Market Analysis and Forecasts, 2021-2029 19.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 19.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 20. Spain Diabetes Management Market Analysis and Forecasts, 2021-2029 20.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 20.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 21. Sweden Diabetes Management Market Analysis and Forecasts, 2021-2029 21.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 21.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 22. CIS Countries Diabetes Management Market Analysis and Forecasts, 2021-2029 22.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 22.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 23. Rest of Europe Diabetes Management Market Analysis and Forecasts, 2021-2029 23.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 23.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 24. Asia Pacific Diabetes Management Market Analysis and Forecasts, 2021-2029 24.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 24.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 25. Asia Pacific Diabetes Management Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2021-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Diabetes Management Market Analysis and Forecasts, 2021-2029 26.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 26.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 27. India Diabetes Management Market Analysis and Forecasts, 2021-2029 27.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 27.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 28. Japan Diabetes Management Market Analysis and Forecasts, 2021-2029 28.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 28.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 29. South Korea Diabetes Management Market Analysis and Forecasts, 2021-2029 29.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 29.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 30. Australia Diabetes Management Market Analysis and Forecasts, 2021-2029 30.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 30.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 31. ASEAN Diabetes Management Market Analysis and Forecasts, 2021-2029 31.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 31.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 32. Rest of Asia Pacific Diabetes Management Market Analysis and Forecasts, 2021-2029 32.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 32.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 33. Middle East Africa Diabetes Management Market Analysis and Forecasts, 2021-2029 33.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 33.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 34. Middle East Africa Diabetes Management Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Diabetes Management Market Analysis and Forecasts, 2021-2029 35.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 35.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 36. GCC Countries Diabetes Management Market Analysis and Forecasts, 2021-2029 36.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 36.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 37. Egypt Diabetes Management Market Analysis and Forecasts, 2021-2029 37.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 37.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 38. Nigeria Diabetes Management Market Analysis and Forecasts, 2021-2029 38.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 38.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 39. Rest of ME&A Diabetes Management Market Analysis and Forecasts, 2021-2029 39.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 39.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 40. South America Diabetes Management Market Analysis and Forecasts, 2021-2029 40.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 40.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 41. South America Diabetes Management Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2021-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Diabetes Management Market Analysis and Forecasts, 2021-2029 42.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 42.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 43. Argentina Diabetes Management Market Analysis and Forecasts, 2021-2029 43.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 43.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 44. Rest of South America Diabetes Management Market Analysis and Forecasts, 2021-2029 44.1. Market Size (Value) Estimates & Forecast By Device Type, 2021-2029 44.2. Market Size (Value) Estimates & Forecast By Therapeutics, 2021-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Diabetes Management Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications, and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Abbott Laboratories 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Bayer AG 45.3.3. Bristol-Myers Squibb 45.3.4. Eli Lilly and Co. 45.3.5. Sanofi 45.3.6. Dexcom 45.3.7. Medtronic 45.3.8. Novo Nordisk A/S 45.3.9. ZydusCadila 45.3.10. BD 45.3.11. Merck & Co. Inc. 45.3.12. F. Hoffmann-La Roche Ltd 45.3.13. Insulet Corporation 45.3.14. LifeScan, Inc. 45.3.15. B. Braun 45.3.16. Tandem Diabetes Care 45.3.17. Ascensia Diabetes Care 45.3.18. Tidepool 45.3.19. Others 46. Primary Key Insights